CDKN2B and myelodysplastic syndrome: p15Ink4b and p21Cip1 downregulation promotes cell cycle progression in the BM haematopoietic cells of MDS and myeloid disease patients and transforms their tendency to undergo apoptosis into apoptosis resistance18–20.